Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GSK2194069 |
Synonyms | |
Therapy Description |
GSK2194069 is a fatty acid synthase (FASN) inhibitor that suppresses tumor cell growth in culture (PMID: 25086508, PMID: 26519059, PMID: 31427815). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GSK2194069 | GSK-2194069|GSK 2194069 | FASN Inhibitor 5 | GSK2194069 is a fatty acid synthase (FASN) inhibitor that suppresses tumor cell growth in culture (PMID: 25086508, PMID: 26519059, PMID: 31427815). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|